May 07, 2019 4:20pm EDT 22nd Century Files 2019 First Quarter Report and Announces Conference Call to Provide Business Update
Apr 30, 2019 9:50am EDT 22nd Century’s Pre-Market Tobacco Application for VLN™ Cigarettes Advances with Completed FDA Inspection
Apr 18, 2019 1:15pm EDT Grossly Misleading “Short and Distort” Article Wrongfully Attempts to Dupe 22nd Century Group Shareholders
Apr 09, 2019 8:05am EDT 22nd Century Announces Exclusive Worldwide Agreement with KeyGene for Genetic Development of Hemp/Cannabis
Mar 27, 2019 9:00am EDT 22nd Century’s New Study Confirms Very Low Nicotine Content Cigarettes Result in 97% Less Nicotine in Smoker’s Bloodstream
Mar 06, 2019 4:15pm EST 22nd Century Files 2018 Annual Report and Announces Conference Call to Provide Business Update
Dec 27, 2018 1:02pm EST 22nd Century Files Modified Risk Tobacco Product (MRTP) Application with the FDA for the Company’s Very Low Nicotine Content Cigarettes
